InnoCare Pharma Limited
General ticker "INCPF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.2B (TTM average)
InnoCare Pharma Limited does not follow the US Stock Market performance with the rate: -27.7%.
Estimated limits based on current volatility of 0.0%: low 1.55$, high 1.55$
Factors to consider:
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.53$, 3.46$]
- 2026-12-31 to 2027-12-31 estimated range: [1.65$, 3.59$]
Short-term INCPF quotes
Long-term INCPF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CNY738.54MM | CNY1,009.45MM | CNY2,297.68MM |
| Operating Expenses | CNY1,389.69MM | CNY1,535.23MM | CNY1,857.05MM |
| Operating Income | CNY-651.15MM | CNY-525.78MM | CNY440.63MM |
| Non-Operating Income | CNY6.95MM | CNY73.19MM | CNY198.19MM |
| Interest Expense | CNY35.03MM | CNY33.79MM | CNY53.65MM |
| R&D Expense | CNY751.18MM | CNY814.03MM | CNY849.24MM |
| Income(Loss) | CNY-644.21MM | CNY-452.59MM | CNY638.82MM |
| Taxes | CNY1.43MM | CNY-0.26MM | CNY11.26MM |
| Net Income(Loss)* | CNY-631.26MM | CNY-440.63MM | CNY625.89MM |
| Stockholders Equity | CNY7,147.85MM | CNY6,725.30MM | CNY7,730.73MM |
| Inventory | CNY119.09MM | CNY95.58MM | CNY162.95MM |
| Assets | CNY9,919.13MM | CNY9,407.49MM | CNY10,829.07MM |
| Operating Cash Flow | CNY-671.34MM | CNY-365.55MM | CNY199.16MM |
| Capital expenditure | CNY254.66MM | CNY78.23MM | CNY68.35MM |
| Investing Cash Flow | CNY666.91MM | CNY1,111.12MM | CNY-358.06MM |
| Financing Cash Flow | CNY1.31MM | CNY-285.60MM | CNY-32.84MM |
| Earnings Per Share** | CNY-0.37 | CNY-0.26 | CNY0.36 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.